Peter Solomon
AUTHOR

Peter Solomon

Tap the gear icon above to manage new release emails.
Dr. Peter Solomon is a scientist, educator, successful entrepreneur, and author. His current mission: to warn the next generation about the threats posed by unchecked science and technology. He is sounding an alarm about the potential tyranny of technology through his novels, 100 Years to Extinction and the sequel, 12 Years to AI Singularity.

Dr. Solomon:

“I believe that astrophysicist Stephen Hawking’s dire prediction of human extinction on Planet Earth by 2117 may be right. The rapid pace of science and technology has far outrun our civilization’s social and political capabilities to control them. The dangers are from fossil fuels, nuclear weapons, uncontrolled artificial intelligence (AI), misused genetic engineering, social media’s disinformation, and plastic pollution. My mission is to raise awareness and urgency in humanity’s effort to confront and control the technological threats. Science and technology will shape the future of humanity—and my passion is making their complexities understandable to all. I believe the most powerful way to reach non-scientists is through storytelling. We must come together as one global community—what I call THE EARTHLING TRIBE. It’s time to MAKE EARTH GREAT AGAIN.”

After earning his PhD in physics from Columbia University, Dr. Peter Solomon launched a distinguished career at the United Technologies Research Center before founding five companies. Four are still operating and one was sold. Over his career, Dr. Solomon has been awarded 20 patents, authored more than 300 scientific publications, and served as Principal Investigator on more than 25 million dollars in U. S. government research contracts and grants over two decades. In 1991, Dr. Solomon won the American Chemical Society (ACS) National Henry H. Storch Award in Fuel Chemistry.
Read more Read less

Best Sellers

Product List
  • 100 Years to Extinction cover art
    Preview

    ₹845.37 or free with 30-day trial

    Free with 30-day trial